Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Novartis raises sales growth target to 5% a year through 2027

    www.aol.com/news/novartis-lifts-sales-growth...

    FRANKFURT (Reuters) -Novartis has dialled up its sales growth target to 5% per year until 2027, citing demand for innovative drugs after the spin off of its generics business. The medium-term ...

  3. Novartis lifts profit forecast for second time on Cosentyx ...

    www.aol.com/news/novartis-raises-2024-profit...

    Swiss drugmaker Novartis raised its 2024 earnings guidance for the second time on Thursday, driven by a gain in prescriptions for drugs including heart failure treatment Entresto and arthritis ...

  4. Novartis drug candidate scores interim win in rare kidney ...

    www.aol.com/news/novartis-says-drug-candidate...

    October 30, 2023 at 6:30 AM. By Ludwig Burger. FRANKFURT (Reuters) -Novartis said its experimental drug atrasentan was shown to have a positive effect on an indicator of kidney health in people ...

  5. Nilotinib - Wikipedia

    en.wikipedia.org/wiki/Nilotinib

    Nilotinib, sold under the brand name Tasigna marketed worldwide by Novartis, is a medication used to treat chronic myelogenous leukemia (CML) which has the Philadelphia chromosome. [4] It may be used both in initial cases of chronic phase CML as well as in accelerated and chronic phase CML that has not responded to imatinib. [4] [5] It is taken ...

  6. 1976–77 United States network television schedule - Wikipedia

    en.wikipedia.org/wiki/1976–77_United_States...

    The following is the 1976–77 network television schedulefor the three major English language commercial broadcast networks in the United States. The schedule covers primetimehours from September 1976 through August 1977. The schedule is followed by a list per networkof returning series, new series, and series cancelled after the 1975–76 season.

  7. US FDA approves Novartis' kidney disease drug - AOL

    www.aol.com/news/us-fda-approves-novartis-kidney...

    August 7, 2024 at 2:23 PM. By Sriparna Roy. (Reuters) -The U.S. Food and Drug Administration has approved the use of Novartis' drug to reduce excess protein in the urine of patients with a type of ...

  8. Vasant Narasimhan - Wikipedia

    en.wikipedia.org/wiki/Vasant_Narasimhan

    He spent 8 years working in Novartis Vaccines, at the time a non-profit division focused on developing vaccines for children and patients around the world and served as the Global Head of Development, Novartis Vaccines in the US between 2012 and 2014 before moving to Sandoz as Global Head of Biopharmaceuticals and Oncology Injectables. [6] [17]

  9. Novartis in advanced talks to buy Cytokinetics- source - AOL

    www.aol.com/news/novartis-advanced-talks-buy...

    Novartis is poised to prevail in the auction for Cytokinetics, ahead of other bidders that include AstraZeneca and Johnson & Johnson, according to the source. A deal could be announced as early as ...